Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P.; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G., Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET., «MOLECULAR IMAGING AND BIOLOGY», 2010, 12, pp. 616 - 625 [articolo]
Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Zinzani P; Fanti S., FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2010, 54, pp. 436 - 441 [articolo]
Nanni C.; Fanti S., FDG-PET and PET/CT for evaluating soft tissue sarcomas, in: HUSTINX R., Musculoskeletal PET imaging, PHILADELPHIA, W.B. Saunders Company, 2010, pp. 341 - 347 [capitolo di libro]
Lopci E; Santi I; Derenzini E; Fonti C; Savelli G; Bertagna F; Bellò M; Botto B; Huglo D; Morschhauser F; Zinzani P; Fanti S., FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study., «ANNALS OF ONCOLOGY», 2010, 21, pp. 1877 - 1883 [articolo]
Ambrosini V; Tomassetti P; Franchi R; Fanti S., Imaging of NETs with PET radiopharmaceuticals., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2010, 54, pp. 16 - 23 [articolo]
Fanti S.; Nanni C.; Lopci E.; Castellucci P.; Rubello D.; Farsad M.; Boschi S., Imaging with (11)Carbon labelled PET tracers., «NUCLEAR MEDICINE COMMUNICATIONS», 2010, 31(7), pp. 613 - 616 [articolo]
Derenzini E; Fina MP; Stefoni V; Pellegrini C; Venturini F; Broccoli A; Gandolfi L; Pileri S; Fanti S; Lopci E; Castellucci P; Agostinelli C; Baccarani M; Zinzani PL., MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients., «ANNALS OF ONCOLOGY», 2010, 21, pp. 1173 - 1178 [articolo]
Martorana G; Schiavina R; Picchio M; Castellucci P; Fanti S; Scattoni V; Farsad M; Nicolai N; Necchi A; Piva L; Tana S; Colecchia M; Crippa F; Spreafico C; Salvioni R, PET in diagnostica Urologica, Roma, Società Italiana di Urologia, 2010, pp. 73 . [libro]
Fanti S.; Farsad M.; Mansi L., PET-CT Beyond FDG, VERLAG BERLIN HEIDELBERG, Springer, 2010, pp. 243 . [libro]
Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M., Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients., «CLINICAL CANCER RESEARCH», 2010, 16(15), pp. 3998 - 4004 [articolo]
Pantaleo M.A.; Nicoletti G.; Nanni C.; Gnocchi C.; Landuzzi L.; Quarta C.; Boschi S.; Nannini M.; Di Battista M.; Castellucci P.; Fanti S.; Lollini P.L.; Bellan E.; Castelli M.; Rubello D.; Biasco G., Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET., «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2010, 29, pp. 173/1 - 173/7 [articolo]
Virgolini I.; Ambrosini V.; Bomanji J.B.; Baum R.P.; Fanti S.; Gabriel M.; Papathanasiou N.D.; Pepe G.; Oyen W.; De Cristoforo C.; Chiti A., Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2010, 37(10), pp. 2004 - 2010 [articolo]
Fuccio C.; Castellucci P.; Schiavina R.; Santi I.; Allegri V.; Pettinato V.; Boschi S.; Martorana G.; Al-Nahhas A.; Rubello D.; Fanti S., Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy., «ANNALS OF NUCLEAR MEDICINE», 2010, 24, pp. 485 - 492 [articolo]
Campana D.; Ambrosini V.; Pezzilli R.; Fanti S.; Labate A.M.; Santini D.; Ceccarelli C.; Nori F.; Franchi R.; Corinaldesi R.; Tomassetti P., Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors., «THE JOURNAL OF NUCLEAR MEDICINE», 2010, 51(3), pp. 353 - 359 [articolo]
Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M., Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2010, 10(4), pp. 258 - 261 [articolo]
